A typical father and son project might mean restoring a classic car or completing a home renovation, but this Christchurch pair have set their sights a little higher. LEE KENNY reports.
Phil and Anthony Butlerhave utilised cutting-edge technologyused in the hunt for the Higgs Boson to invent the world's first 3-D colour X-ray.
Phil is a professor at University of Canterbury and a Fellow of New Zealand Institute of Physics, while Anthony is a clinical radiologist and a professor at University of Otago.
Together they have created the MARS scanner, which will one day replace many of the functions of the X-ray, positron emission tomography (PET) scans and magnetic resonance imaging (MRI).
Phil and Anthony Butler work on an arm scanner at MARS' Christchurch laboratory.
READ MORE:* What will be the biggest scientific breakthrough of 2020?* Defence Force medic's bleeding edge invention wins Manawat's Innovate 2019* Where did the curiosity go?
The non-invasive technique will enable doctors to see colour images from inside the body, allowing them to make a more accurate diagnosis when treating everything from a broken bone to heart disease.
Phil, 72, first thought about the concept while he was atCERN (European Organization for Nuclear Research) in 2002.
Scientists working on the Large Hadron Collider used high-tech Medipix detectors to track particles and it was theorisedthey could also be used to detect X-ray photons.
Anthony joined CERN in 2005 and it was while the Butlerswere on a family holiday in Croatia that they decided to put the theory to the test.
A 3-D image of Phil Butler's wrist taken by the MARS scanner in 2018.
They founded MARS Bioimaging in 2007 and today their 50-strong team consists of physicists, radiologists, mathematicians, biologists, engineers and computer scientists.
The company is part owned by University of Canterbury where it is based and has close ties to Otago Medical School.
Anthony, 44, explains the machine works by shining X-rays through the body and measuring the tissue composition before a computer reconstructs the information into a high-resolution 3-D colour image.
"The underlying process is often called spectral photon counting we measure the X-ray beam one photon at a time, which means we need to have very fast electronics to do this."
He says they have been looking at several medical applications for the scanners, across a range of clinical disciplines.
Professor Phil Butler is the chief executive of MARS Bioimaging but still takes a hands-on role.
"We've been working with orthopedic surgeons looking at fracture healing, cardiologists looking at the causes of heart disease and stroke, cancer specialists looking whether we can look at cell lines and the way they progress and we've looked at infectious diseases.
"That covers a large chunk of medicine and I expect we'll see [the scanners]hit the clinics at different times.
"It's going to be routine within a few years for a lot of point-of-care stuff."
The primary difference between the MARS scanner and other techniques is the level of detailed information it can record.
Anthony says the work is so cutting edge that components had to be built from scratch.
The MARS scanner was inspired by technology used at CERN, the World's Largest Particle Physics Laboratory.
"We did computer simulations to work out what we should be doing, then we had to come up with the designs, then manufacture it."
Dipanjan Pan, professor in chemical and biological engineering and radiology at University of Maryland Baltimore County, is an expert in nanomedicine and molecular imaging.
He collaborated with the MARS team for several years and says the3-D scanner has the potential to "dramatically change the ambiguity often found in black and white conventional CT imaging".
"Looking through MARS's proprietary photon counting CT 'magic lenses', you are visualising in colour the future of various biological processes as it merges with the present," he says.
"Their powerful reconstruction technique is astounding."
The technology has a range of uses from security and engineeringto physics and astronomy.
The traditional 2-D X-ray is good at showing solid objects like bones.
But the Butlers are focused on clinical applications and in July 2018 Phil became the first person to be scanned, with images generated of his wrist and ankle.
The next stage will be clinical trials next year when orthopaedic and rheumatology patients from Christchurch will bescanned.
Phil saysthe breakthrough is comparable to the first X-ray images in 1895 and the first low-resolution Computed Tomography (CT) in 1972.
"It's a major step. We went from 2-D to 3-D, now we're going from black and white to colour.
"The other thing that makes ours different from pretty much any other clinical system is we've got very high-resolution, basically 10 times the resolution of any other comparable technology."
Dr Diana Siew, associate director at MedTech Centre of Research Excellence at Auckland Bioengineering Institute, said the MARS X-ray scanner is a "game changer in medical diagnostics" because "it visualises what is happening in the body in a way that has not been achieved before".
"Different components of the body like fat, calcium, water and disease biomarkers show-up on the X-ray images in different colours, thus allowing a fuller and more accurate picture of a patient's condition," she says.
The new MRI scanner at Palmerston North Hospital had to be slotted through a hole in the wall when it was installed in April 2019.
"From a research perspective, this is exciting as it could underpin new understanding of disease onset and progression and be used to determine the efficacy of treatments.
"The MARS technology is a world's first and it is so exciting that it is happening in NZ."
As well as heralding a quantum leap in imaging capability, Anthony says the MARS technology will improve health treatment for Kiwis, as not everywhere has access to PET or MRI scanners.
"About half the people in rural New Zealand don't get appropriate cancer treatment, not because the country can't afford it but because the cancer centres are in large hospitals, the same is true for imaging," he says.
"If you are on the West Coast you cannot get a PET scan, you have to come over to Christchurch.
MRI scanners can record incredible detail but they are large and not widely available.
"So those access issues, we beat most of them because we use X-rays and they are very easy to have in a local practice, every dentist has got one."
Phil added: "One of the design goals for this system is to make it as easy to operate as a dentist's X-ray".
As well as the high cost of PET and MRI scanners, Anthony says there are other practicalities that make them less accessible.
"MRI requires rooms with big machines, you have to have liquid helium cooling it down, you can't put someone in with a pacemaker, certain vascular clips can't go in there [or] hip replacements," he says.
"With PET you have similar things, you have radioisotopes. In New Zealand we have one cyclotron in Wellington producing radioisotopes and they have to be flown around the country, so if it's a windy day in Wellington, no PET imaging can happen in the country."
A 3-D image of Phil Butler's ankle, scanned in 2018.
MARS is operated from a secure area of University of Canterbury and as well as full-time staff, research is carried out by 15 PhD candidates.
Phil is in no doubt that a key component of the project's success is that it's based in Canterbury.
"If you look at the electronics or mechanical engineering skills of Christchurch, we can build anything," he says.
"We've got the skills to do it but the people also know each other, whereas if you go to a big city of several million, they can do it but they can't talk to their allied disciplines.
"That goes back to the farming industries, where people had to build their own machines and those skills of being able to build anything are all part of that."
"If you go to really large research institutes they can be really skilled but they tend to have big silos. In New Zealand we tend not to operate that way.
The Butlers, pictured here in 2010, examine coloured Iodine and Barium infused tissue.
"I think we're the sweet-spot in terms of size, where there's enough skill around that there's experts but we're not so big that we can't talk to each other."
Almost 15 years since the father and son team decided to embark on the research, they have made huge advances but there is still work to be done.
"If you look at where we were in 2006 or 2007 we were able to measure four colours but we had to do them one after the other, not simultaneously," Anthony says.
"We scanned the abdomen of a mouse, a pretty small object, and it [took] a day to image it and a month to do all the data reconstruction to get a picture to look at."
Day-to-day, Anthony is the company's chief medical officer and scientific lead.
Phil is the chief executive but, but according to Anthony, he still "does a lot of the technical work".
Working with family members can bring its challenges but Anthony says one of the advantages of partnering with his dad is the "innate trust" they have.
"It's actually a real pleasure," he says.
"I'm quite lucky, I didn't start working with him until I was in my early 30s, which meant I'd done all of my qualifications, established my own life.
"He had done many things himself and been pro-vice chancellor of the university and wanted to get more into practical applications so we founded this project together and that's been really nice.
"You're always going to have problems in any relationship but the fact that it's a family member gives you structure where you can actually work through problems and solve them and know that you're on the same team."
- Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead... - January 25th, 2020
- Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form N | IJN - Dove Medical Press - January 25th, 2020
- Biomedical Applications of Zeolitic Nanoparticles, with an Emphasis on | IJN - Dove Medical Press - January 25th, 2020
- Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating | IJN - Dove Medical Press - January 25th, 2020
- Healthcare Nanotechnology (Nanomedicine) Market Share, Size, Future Demand, Global Research, Top Leading Player, Emerging Trends and Forecast to 2015 ... - January 25th, 2020
- Advancells Group & IFC Concluded their 3-Day Workshop on Regenerative Medicine - Business Wire India - January 25th, 2020
- I asked Tanzanians about studying in China: here's what they said - The Conversation Africa - January 25th, 2020
- The Future Of Nano Medicine - January 19th, 2020
- Nanomedicine: Nanotechnology, Biology and Medicine ... - January 19th, 2020
- Nanomedicine | medicine | Britannica - January 19th, 2020
- New Approaches in Breast Cancer Therapy Through Green Nanotechnology a | IJN - Dove Medical Press - January 19th, 2020
- Controlled phage therapy hints at future alternative to antibiotics - New Atlas - January 19th, 2020
- A New Old Therapy - The UCSB Current - January 19th, 2020
- Most engineered nanoparticles enter tumours through cells not between them, U of T researchers find - News@UofT - January 19th, 2020
- Rewind 2019: A Look Back at Significant Developments in Indian Science This Year - The Weather Channel - December 27th, 2019
- Electroplating method makes conductive nanostraws for injecting into and sampling from cells - Chemical & Engineering News - December 3rd, 2019
- Protein-Protected Metal Nanoclusters That Behave Like Natural Enzymes - Advanced Science News - December 3rd, 2019
- Design and Synthesis of Gold-Gadolinium-Core-Shell Nanoparticles as Co | IJN - Dove Medical Press - December 3rd, 2019
- Biochips Technologies, Companies, Applications & Markets, 2028 - 94 Companies are Included Along with a Listing of 121 Collaborations Between... - December 3rd, 2019
- Invicro LLC Joins Accenture's INTIENT Network to Help Advance Innovation in Drug Discovery and Scientific Research - BioSpace - December 3rd, 2019
- Nanoparticle therapy shows promise for treatment of rare cancer - The Brown Daily Herald - November 22nd, 2019
- At 9.6% CAGR, Healthcare Nanotechnology Market Global Industry to Reach Valuation over 306100 Million USD by 2025 - Markets Gazette 24 - November 22nd, 2019
- Nanotherapies for Rheumatoid Arthritis: Advantages, Challenges, and Future Direction - Rheumatology Advisor - November 22nd, 2019
- World Pancreatic Cancer Day: increasing awareness and inspiring action - UNSW Newsroom - November 22nd, 2019
- Bankrupt biopharmas are rare. 2019 has some worried that's changing. - BioPharma Dive - November 22nd, 2019
- Healthcare Nanotechnology Market Needs and Demand Analysis 2019 to 2025 - The Chicago Sentinel - November 13th, 2019
- Medical equipment to be infection-free now, says study - Zee News - November 12th, 2019
- Advances in nanomedicine for the treatment of ankylosing spondylitis | IJN - Dove Medical Press - November 1st, 2019
- Market Share in Nanotechnology and Nanomedicine for Treatment of Viral Infections Could Reach Tens of Billion Dollars - P&T Community - November 1st, 2019
- A highly biocompatible and intravenous injectable hafnium oxide nanocrystal synthesized to enhance radiaotherapy efficacy for cancer treatment -... - November 1st, 2019
- Doheny and UCLA Stein Eye Institutes Welcome Kaustabh Ghosh, PhD, to the Scientific and Clinical Research Faculty - PRNewswire - November 1st, 2019
- SUNY Potsdam chemistry professor awarded grant from National Institutes of Health - NNY360 - October 1st, 2019
- Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nano | IJN - Dove Medical Press - October 1st, 2019
- MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019) - BioSpace - October 1st, 2019
- Synthetic networks with tunable responsiveness, biodegradation, and molecular recognition for precision medicine applications - Science Advances - October 1st, 2019
- Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy | IJN - Dove Medical Press - October 1st, 2019
- Nanomanipulator Market Upcoming Trends, Revenue, Key Manufactures and Competitive Analysis till 2025 - One Digi Click - October 1st, 2019
- First-of-its-kind trial in ALS spurs hope for brutal disease - BioPharma Dive - October 1st, 2019
- FBI Investigation Targets Trump Booster Peter Thiel’s VC Firm - September 14th, 2019
- YouTube Influencers Are Mentally Collapsing From Stress - September 14th, 2019
- Watch SpaceX Test Its Crew Dragon’s Escape System - September 14th, 2019
- MIT Team “Accidentally” Invents Blackest Material in Existence - September 14th, 2019
- A Driver Tricked Uber’s Algorithm, Sexually Assaulted a Passenger - September 14th, 2019
- Toyota Wants to Slather Solar Panels All Over Its Prius Hybrid - September 14th, 2019
- A Runaway Star Is Escaping a Black Hole at 1.2 Million MPH - September 14th, 2019
- Putin Critic Uses Drone to Save Hard Drives Before Police Raid - September 14th, 2019
- Airbus Planes Will Track How Often Passengers Go to the Bathroom - September 14th, 2019
- Watch a Robot Fish Fly by Shooting Water out of Its Rear - September 14th, 2019
- Residents Are Trying to Flee Russian Town Where Snow Turned Black - September 14th, 2019
- This Startup Will Send DNA From Your Spit to the Moon for $99 - September 14th, 2019
- Horrifying Study: Corpses Thrash Around For a Year After Death - September 14th, 2019
- French Gov Official Warns Facebook: Libra Is Not Welcome Here - September 14th, 2019
- Watch a Tesla Model X Blast Through Deep Flood Waters - September 14th, 2019
- Milky Way’s Giant Black Hole Lets out Two Giant, Radioactive Burps - September 14th, 2019
- Instagram Keeps Accidentally Flagging Fish Photos as Offensive - September 14th, 2019
- MIT Community Horrified by Famed Researcher’s Epstein Outburst - September 14th, 2019
- Unlike MIT, Harvard Cut Off Epstein Donations After Conviction - September 14th, 2019
- Can You Tell Which of These Models Is CGI? - May 28th, 2019
- We Asked an AI to Finish Real Elon Musk Tweets - May 28th, 2019
- Watch a Super-Strong Robot Dog Pull a Three-Ton Airplane - May 28th, 2019
- Asteroid Flying by Earth Is so Big It Has Its Own Moon - May 28th, 2019
- United Nations: Siri and Alexa Are Encouraging Misogyny - May 28th, 2019
- New Law Could End Robocalling Once and For All - May 28th, 2019
- Scientists Set New Temperature Record for Superconductivity - May 28th, 2019
- Elevate Your Leadership and Grow Your Business at Your Clouds Can 2019 - May 28th, 2019
- NASA’s Moon Mission Leader Just Quit After Only Six Weeks - May 28th, 2019
- Watch a Tesla in an Underground Tunnel Race One on the Street - May 28th, 2019
- SpaceX Just Unleashed 60 Starlink Satellites Into Orbit - May 28th, 2019
- Elon Musk Ridicules Jeff Bezos’ Plan For Space Colonies - May 28th, 2019
- See China’s Newly Unveiled Maglev Train - May 28th, 2019
- Here’s How NASA Prepares Its Spacecraft for Mars - May 28th, 2019
- This Robot Scans Preschoolers’ Faces Daily for Signs of Sickness - May 28th, 2019
- New Research: The Oceans Are Slowly Leaking Into the Earth - May 28th, 2019
- Studying the Sun’s Atmosphere Could Make Fusion Power a Reality - May 28th, 2019
- NASA Just Hired the First Contractor to Build Lunar Space Station - May 28th, 2019
- Anonymous Group of 3D-Printed Gun Makers Is Spreading Online - May 28th, 2019
- Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More - May 25th, 2019
- Cryptocurrency News: This Week on Bitfinex, Tether, Coinbase, & More - May 25th, 2019
- Cryptocurrency News: Bitcoin ETFs, Andreessen Horowitz, and Contradictions in Crypto - May 25th, 2019
- Cryptocurrency News: Looking Past the Bithumb Crypto Hack - May 25th, 2019